• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效的睡眠美人 DNA 转座从 DNA 微环。

Efficient sleeping beauty DNA transposition from DNA minicircles.

机构信息

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

出版信息

Mol Ther Nucleic Acids. 2013 Feb 26;2(2):e74. doi: 10.1038/mtna.2013.1.

DOI:10.1038/mtna.2013.1
PMID:23443502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3586802/
Abstract

DNA transposon-based vectors have emerged as new potential delivery tools in therapeutic gene transfer. Such vectors are now showing promise in hematopoietic stem cells and primary human T cells, and clinical trials with transposon-engineered cells are on the way. However, the use of plasmid DNA as a carrier of the vector raises safety concerns due to the undesirable administration of bacterial sequences. To optimize vectors based on the Sleeping Beauty (SB) DNA transposon for clinical use, we examine here SB transposition from DNA minicircles (MCs) devoid of the bacterial plasmid backbone. Potent DNA transposition, directed by the hyperactive SB100X transposase, is demonstrated from MC donors, and the stable transfection rate is significantly enhanced by expressing the SB100X transposase from MCs. The stable transfection rate is inversely related to the size of circular donor, suggesting that a MC-based SB transposition system benefits primarily from an increased cellular uptake and/or enhanced expression which can be observed with DNA MCs. DNA transposon and transposase MCs are easily produced, are favorable in size, do not carry irrelevant DNA, and are robust substrates for DNA transposition. In accordance, DNA MCs should become a standard source of DNA transposons not only in therapeutic settings but also in the daily use of the SB system.Molecular Therapy - Nucleic Acids (2013) 2, e74; doi:10.1038/mtna.2013.1; published online 26 February 2013.

摘要

基于 DNA 转座子的载体已成为治疗性基因转移的新的潜在递药工具。此类载体目前在造血干细胞和原代人 T 细胞中显示出前景,采用转座子工程化细胞的临床试验正在进行中。然而,由于细菌序列的不期望的给药,将质粒 DNA 用作载体可能会引发安全性问题。为了优化基于 Sleeping Beauty(SB)DNA 转座子的载体用于临床应用,我们在此检查了不含细菌质粒骨架的 DNA 微环(MC)中的 SB 转座。从 MC 供体中证明了由超活性 SB100X 转座酶指导的有效的 DNA 转座,并且通过从 MC 表达 SB100X 转座酶来显著增强稳定转染率。稳定转染率与环状供体的大小呈反比,这表明基于 MC 的 SB 转座系统主要受益于增加的细胞摄取和/或可观察到的 DNA MC 中增强的表达。DNA 转座子和转座酶 MC 易于制备,大小有利,不携带无关 DNA,并且是 DNA 转座的稳健底物。因此,DNA MC 不仅应成为治疗性设置中,而且还应成为 SB 系统日常使用中的 DNA 转座子的标准来源。

Molecular Therapy - Nucleic Acids (2013) 2, e74; doi:10.1038/mtna.2013.1; published online 26 February 2013.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/4c482be0081a/mtna20131f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/6198831ba297/mtna20131f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/6b4454b55234/mtna20131f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/b37da66cf6bd/mtna20131f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/99432a9623cd/mtna20131f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/4c482be0081a/mtna20131f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/6198831ba297/mtna20131f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/6b4454b55234/mtna20131f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/b37da66cf6bd/mtna20131f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/99432a9623cd/mtna20131f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb5/3586802/4c482be0081a/mtna20131f5.jpg

相似文献

1
Efficient sleeping beauty DNA transposition from DNA minicircles.高效的睡眠美人 DNA 转座从 DNA 微环。
Mol Ther Nucleic Acids. 2013 Feb 26;2(2):e74. doi: 10.1038/mtna.2013.1.
2
Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological Overview.基于睡美人转座子的 CAR T 细胞生产用微小环:技术概述。
Methods Mol Biol. 2022;2521:25-39. doi: 10.1007/978-1-0716-2441-8_2.
3
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors.微环 Sleeping Beauty 转座子载体高效非病毒基因转导入人造血干细胞。
Mol Ther. 2018 Apr 4;26(4):1137-1153. doi: 10.1016/j.ymthe.2018.01.012. Epub 2018 Jan 31.
4
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.一种通过包装到整合缺陷型慢病毒载体中的转录调控睡眠美系统实现的高效体外转座方法。
J Vis Exp. 2018 Jan 12(131):56742. doi: 10.3791/56742.
5
Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.利用转座酶介导的体细胞整合的杂交腺相关病毒载体在人细胞中稳定表达转基因。
PLoS One. 2013 Oct 8;8(10):e76771. doi: 10.1371/journal.pone.0076771. eCollection 2013.
6
Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.在培养的哺乳动物细胞中,用于睡美人介导转座的转座子和转座酶功能的反选择和共递送。
Biosci Rep. 2004 Dec;24(6):577-94. doi: 10.1007/s10540-005-2793-9.
7
Transposons: Moving Forward from Preclinical Studies to Clinical Trials.转座子:从临床前研究迈向临床试验。
Hum Gene Ther. 2017 Nov;28(11):1087-1104. doi: 10.1089/hum.2017.128. Epub 2017 Aug 22.
8
Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.“睡美人”,一种用于脊椎动物基因转化的广泛宿主范围转座子载体。
J Mol Biol. 2000 Sep 8;302(1):93-102. doi: 10.1006/jmbi.2000.4047.
9
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor.高活性睡美人转座酶 SB100X 可提高 T 细胞表达嵌合抗原受体的基因修饰效率。
Gene Ther. 2011 Sep;18(9):849-56. doi: 10.1038/gt.2011.40. Epub 2011 Mar 31.
10
Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.基于微型环状DNA的嵌合抗原受体(CAR)T细胞工程
Recent Results Cancer Res. 2016;209:37-50. doi: 10.1007/978-3-319-42934-2_3.

引用本文的文献

1
Emerging CAR immunotherapies: broadening therapeutic horizons beyond cancer.新兴的嵌合抗原受体免疫疗法:拓展癌症以外的治疗视野。
Clin Exp Med. 2025 Aug 4;25(1):274. doi: 10.1007/s10238-025-01820-x.
2
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors.使用下一代纳米质粒载体提高细胞和基因治疗的安全性及性能。
Mol Ther Nucleic Acids. 2023 Apr 7;32:494-503. doi: 10.1016/j.omtn.2023.04.003. eCollection 2023 Jun 13.
3
The Past, Present, and Future of Non-Viral CAR T Cells.非病毒 CAR T 细胞的过去、现在和未来。

本文引用的文献

1
The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells.cHS4 绝缘子对视网膜色素上皮细胞中 DNA 转座子载体转导和沉默的影响。
PLoS One. 2012;7(10):e48421. doi: 10.1371/journal.pone.0048421. Epub 2012 Oct 26.
2
New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.新一代无抗生素抗性标记质粒骨架,用于基因治疗试验。
Mol Ther. 2011 Nov;19(11):1942-9. doi: 10.1038/mt.2011.182. Epub 2011 Aug 30.
3
Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
Front Immunol. 2022 Jun 9;13:867013. doi: 10.3389/fimmu.2022.867013. eCollection 2022.
4
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.北极地区新型常染色体隐性 IFNAR2 缺陷导致危及生命的病毒性疾病。
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20212427. Epub 2022 Apr 20.
5
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.卡拉巴:首例采用无病毒 Sleeping Beauty 基因转导制备的 SLAMF7 CAR-T 细胞治疗多发性骨髓瘤的人体临床试验。
Gene Ther. 2021 Sep;28(9):560-571. doi: 10.1038/s41434-021-00254-w. Epub 2021 Apr 13.
6
Enhanced Tailored MicroRNA Sponge Activity of RNA Pol II-Transcribed TuD Hairpins Relative to Ectopically Expressed ciRS7-Derived circRNAs.与异位表达的ciRS7衍生环状RNA相比,RNA聚合酶II转录的TuD发夹的增强型定制微小RNA海绵活性。
Mol Ther Nucleic Acids. 2018 Dec 7;13:365-375. doi: 10.1016/j.omtn.2018.09.009. Epub 2018 Sep 21.
7
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors.微环 Sleeping Beauty 转座子载体高效非病毒基因转导入人造血干细胞。
Mol Ther. 2018 Apr 4;26(4):1137-1153. doi: 10.1016/j.ymthe.2018.01.012. Epub 2018 Jan 31.
8
Preclinical and clinical advances in transposon-based gene therapy.基于转座子的基因治疗的临床前和临床进展。
Biosci Rep. 2017 Dec 5;37(6). doi: 10.1042/BSR20160614. Print 2017 Dec 22.
9
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives.用于稳定基因治疗的逆转录病毒载体和转座子:进展、当前挑战与展望
J Transl Med. 2016 Oct 12;14(1):288. doi: 10.1186/s12967-016-1047-x.
10
Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors.使用源自微环载体的非病毒 Sleeping Beauty 转座子增强 CAR T 细胞工程。
Leukemia. 2017 Jan;31(1):186-194. doi: 10.1038/leu.2016.180. Epub 2016 Jun 24.
高效整合缺陷型慢病毒载体介导的睡眠美人转座子在原代人细胞中的基因组整合特性比较分析。
Mol Ther. 2011 Aug;19(8):1499-510. doi: 10.1038/mt.2011.47. Epub 2011 Apr 5.
4
The Sleeping Beauty transposon system: a non-viral vector for gene therapy.睡美人转座子系统:一种非病毒基因治疗载体。
Hum Mol Genet. 2011 Apr 15;20(R1):R14-20. doi: 10.1093/hmg/ddr140. Epub 2011 Apr 1.
5
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor.高活性睡美人转座酶 SB100X 可提高 T 细胞表达嵌合抗原受体的基因修饰效率。
Gene Ther. 2011 Sep;18(9):849-56. doi: 10.1038/gt.2011.40. Epub 2011 Mar 31.
6
Lifelong reporter gene imaging in the lungs of mice following polyethyleneimine-mediated sleeping-beauty transposon delivery.聚乙烯亚胺介导的睡美人转座子递送后,小鼠肺部的终身报告基因成像。
Biomaterials. 2011 Mar;32(7):1978-85. doi: 10.1016/j.biomaterials.2010.11.026. Epub 2010 Dec 17.
7
A robust system for production of minicircle DNA vectors.一种用于生产微环 DNA 载体的稳健系统。
Nat Biotechnol. 2010 Dec;28(12):1287-9. doi: 10.1038/nbt.1708. Epub 2010 Nov 21.
8
Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I.基于微环 DNA 的基因治疗与免疫调节相结合,可使黏多糖贮积症 I 型小鼠长期表达 α-L-艾杜糖苷酶。
Mol Ther. 2011 Mar;19(3):450-60. doi: 10.1038/mt.2010.249. Epub 2010 Nov 16.
9
Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.将睡美人转位应用于细胞治疗:胜利与挑战。
Bioessays. 2010 Sep;32(9):756-67. doi: 10.1002/bies.201000027.
10
Novel minicircle vector for gene therapy in murine myocardial infarction.用于小鼠心肌梗死基因治疗的新型微环载体
Circulation. 2009 Sep 15;120(11 Suppl):S230-7. doi: 10.1161/CIRCULATIONAHA.108.841155.